Success Metrics

Completion Rate
0%(0/1)
Active Trials
4(57%)
Terminated
1(14%)

Phase Distribution

Ph phase_1
2
29%
Ph phase_2
2
29%
Ph phase_3
2
29%
Ph not_applicable
1
14%

Phase Distribution

2

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
2(28.6%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

4

trials recruiting

Total Trials

7

all time

Status Distribution
Active(4)
Terminated(1)
Other(2)

Detailed Status

Recruiting2
Active, not recruiting2
Terminated1
unknown1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
4
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (28.6%)
Phase 22 (28.6%)
Phase 32 (28.6%)
N/A1 (14.3%)

Trials by Status

terminated114%
recruiting229%
active_not_recruiting229%
unknown114%
suspended114%

Recent Activity

4 active trials
Showing 5 of 7
recruitingphase_1

A Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a Stroke

NCT07318714
active_not_recruitingphase_2

Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma

NCT04225039
active_not_recruitingphase_3

Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases

NCT05438212
recruitingphase_1

Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors

NCT06650163
suspendednot_applicable

Surgical Resection of Latent Brain Tumors Prior to Recurrence

NCT04810871
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07318714Phase 1

A Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a Stroke

Recruiting
NCT04225039Phase 2

Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma

Active Not Recruiting
NCT05438212Phase 3

Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases

Active Not Recruiting
NCT06650163Phase 1

Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors

Recruiting
NCT04810871Not Applicable

Surgical Resection of Latent Brain Tumors Prior to Recurrence

Suspended
NCT04474925Phase 3

Pre- Versus Post-operative SRS for Resectable Brain Metastases

Terminated
NCT05084092Phase 2

IORT After Surgical Resection of Brain Metastases

Unknown

All 7 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
7